V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 2.49 USD -0.4%
Market Cap: 69.3m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
VistaGen Therapeutics Inc

Current Assets 99.9m
Cash & Short-Term Investments 97.6m
Other Current Assets 2.4m
Non-Current Assets 2.5m
PP&E 2.1m
Other Non-Current Assets 498k
Current Liabilities 7.5m
Accounts Payable 715k
Accrued Liabilities 4.3m
Other Current Liabilities 2.5m
Non-Current Liabilities 2m
Other Non-Current Liabilities 2m

Balance Sheet
VistaGen Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
0
0
3
10
13
1
103
68
17
119
Cash Equivalents
0
0
3
10
13
1
103
68
17
119
Total Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
1
1
0
0
1
3
1
2
Total Current Assets
0
1
3
11
14
2
104
71
18
121
PP&E Net
0
0
0
0
0
4
4
3
3
2
PP&E Gross
0
0
0
0
0
4
4
3
3
2
Accumulated Depreciation
0
0
0
0
1
1
1
1
1
1
Other Long-Term Assets
0
0
0
0
0
0
1
1
1
1
Total Assets
0
N/A
1
+233%
4
+270%
11
+205%
14
+24%
6
-59%
108
+1 767%
75
-31%
21
-72%
124
+486%
Liabilities
Accounts Payable
2
1
1
1
1
2
1
3
3
2
Accrued Liabilities
1
1
0
0
2
1
2
2
1
3
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
14
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
1
1
1
1
Total Current Liabilities
17
2
1
2
3
3
4
6
5
5
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Liabilities
3
2
2
3
4
9
12
4
4
4
Total Liabilities
21
N/A
4
-81%
3
-23%
4
+42%
7
+57%
12
+67%
16
+42%
10
-39%
9
-9%
9
+4%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
85
132
142
157
181
202
220
268
327
356
Additional Paid In Capital
68
133
147
167
192
200
316
336
343
474
Treasury Stock
4
4
4
4
4
4
4
4
4
4
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
21
N/A
3
+85%
1
N/A
7
+1 050%
7
+3%
6
N/A
92
N/A
65
-30%
12
-81%
114
+845%
Total Liabilities & Equity
0
N/A
1
+233%
4
+270%
11
+205%
14
+24%
6
-59%
108
+1 767%
75
-31%
21
-72%
124
+486%
Shares Outstanding
Common Shares Outstanding
0
0
0
1
1
2
6
7
7
27
Preferred Shares Outstanding
1
7
4
4
4
4
4
0
0
0

See Also

Discover More